skip to Main Content

Ongoing Research in Pancreatic Cancer Focusing on Molecular Targets

Newsfeed image, light gray text on dark gray background
Explorative therapeutic strategies for patients with pancreatic cancer continue to move through the clinical trial pipeline, comprising targeted therapy, stromal modulation, and metabolic agents, with the niche for immunotherapy still being debated, explained Eileen M. O’Reilly, MD.
Read more . . . 

 


Back To Top